One well-studied mouse model of RAS-driven pancreatic cancer combines a conditional oncogenic KRAS allele induced by a pancreatic-specific Cre on the background of a loss of either the tumor suppressor p53 or INK4/ARF, (reviewed in [17, 18]). This evidence concerns the gene CDKN2A and pancreatic neoplasm.